<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
<channel>
<title><![CDATA[RSS for Merck]]></title>
<description><![CDATA[Watch breaking news videos and read news updates about Merck on FOXBusiness.com.]]></description>
<link><![CDATA[http://www.foxbusiness.com/search-results/]]></link>
<atom:link xmlns:atom="http://www.w3.org/2005/Atom" type="application/rss+xml" rel="self" href="http://www.foxbusiness.com/search-results/urss?pageid=53609"/>
<item>
<title><![CDATA[MARKET SNAPSHOT: U.S. Stocks Drop, Retreating From All-time Highs]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/20/market-snapshot-us-stocks-drop-retreating-from-all-time-highs/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/20/market-snapshot-us-stocks-drop-retreating-from-all-time-highs/</guid>
<pubDate><![CDATA[Mon, 20 May 2013 16:38:24 EDT]]></pubDate>
<description><![CDATA[U.S. stocks finished lower on Monday after comments from Chicago Federal Reserve President Charles Evans knocked them from new all-time highs set earlier in the day.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[FDA Staff: Merck Sleep Drug Effective but Some Dosage Concerns]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/20/fda-staff-merck-sleep-drug-effective-but-some-dosage-concerns/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/20/fda-staff-merck-sleep-drug-effective-but-some-dosage-concerns/</guid>
<pubDate><![CDATA[Mon, 20 May 2013 16:30:44 EDT]]></pubDate>
<description><![CDATA[Food and Drug Administration staff on Monday said a proposed sleep drug from Merck & Co. (MRK) is effective, but questioned the safety of the product's higher doses.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[FDA Staff: Merck Sleep Drug Effective; Safety Concerns With Higher Doses]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/20/fda-staff-merck-sleep-drug-effective-safety-concerns-with-higher-doses/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/20/fda-staff-merck-sleep-drug-effective-safety-concerns-with-higher-doses/</guid>
<pubDate><![CDATA[Mon, 20 May 2013 09:08:23 EDT]]></pubDate>
<description><![CDATA[Food and Drug Administration staff said a proposed sleep drug from Merck & Co. (MRK) was effective, but questioned the safety of the product's higher doses.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Pair of Studies Show Power of Immune System to Fight Cancer]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/15/pair-studies-show-power-immune-system-to-fight-cancer/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/15/pair-studies-show-power-immune-system-to-fight-cancer/</guid>
<pubDate><![CDATA[Wed, 15 May 2013 18:15:27 EDT]]></pubDate>
<description><![CDATA[Positive results from two early-stage studies of drugs from Bristol-Myers Squibb Co. (BMY) and Roche Holding AG (RHHBY) provided fresh evidence that the power of the immune system is emerging as a promising new weapon against cancer.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Merck KGaA to Reach 2014 Outlook One Year Early, 1Q Profit Up]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/14/merck-kgaa-to-reach-2014-outlook-one-year-early-1q-profit-up/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/14/merck-kgaa-to-reach-2014-outlook-one-year-early-1q-profit-up/</guid>
<pubDate><![CDATA[Tue, 14 May 2013 01:53:11 EDT]]></pubDate>
<description><![CDATA[German pharmaceutical retailer Merck KGaA (MRK.XE) Tuesday said it expects to achieve the guidance it gave for 2014 already one year earlier, after reporting a solid earnings increase in the first quarter, due to a lower level of inventory write-downs and changes in the product mix.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[EARNINGS FORECAST TABLE: Merck KGaA 1Q 2013]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/13/earnings-forecast-table-merck-kgaa-1q-2013/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/13/earnings-forecast-table-merck-kgaa-1q-2013/</guid>
<pubDate><![CDATA[Mon, 13 May 2013 08:53:23 EDT]]></pubDate>
<description><![CDATA[The following is a summary of analysts' forecasts for Merck KGaA (MRK.XE) first-quarter results, based on a poll of eight analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS).]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[AbbVie Chief Scientific Officer John Leonard to Retire]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/10/abbvie-chief-scientific-officer-john-leonard-to-retire/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/10/abbvie-chief-scientific-officer-john-leonard-to-retire/</guid>
<pubDate><![CDATA[Fri, 10 May 2013 17:05:26 EDT]]></pubDate>
<description><![CDATA[AbbVie Inc. (ABBV), the pharmaceutical business spun off from Abbott Laboratories (ABT), said its head of research and development will retire from the company.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Analysis: Drugmakers face more scrutiny of discordant U.S. prices]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/10/analysis-drugmakers-face-more-scrutiny-discordant-us-prices/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/10/analysis-drugmakers-face-more-scrutiny-discordant-us-prices/</guid>
<pubDate><![CDATA[Fri, 10 May 2013 11:20:07 EDT]]></pubDate>
<description><![CDATA[The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Merck sales rep claims sexual bias, seeks over $100 million]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/09/merck-sales-rep-claims-sexual-bias-seeks-over-100-million/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/09/merck-sales-rep-claims-sexual-bias-seeks-over-100-million/</guid>
<pubDate><![CDATA[Thu, 09 May 2013 11:26:41 EDT]]></pubDate>
<description><![CDATA[A senior sales representative for Merck & Co has sued the drugmaker for more than $100 million, alleging it discriminates against female employees in terms of pay and advancement, particularly pregnant employees and women with children.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Merck: FDA Accepts Application for Dissolvable Ragweed Allergy Pill]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/08/merck-fda-accepts-application-for-dissolvable-ragweed-allergy-pill/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/08/merck-fda-accepts-application-for-dissolvable-ragweed-allergy-pill/</guid>
<pubDate><![CDATA[Wed, 08 May 2013 09:12:20 EDT]]></pubDate>
<description><![CDATA[Merck & Co. (MRK) said the U.S. Food and Drug Administration has accepted its biologics license application for a dissolvable tablet to treat ragweed pollen allergies and expects the agency to complete its review in the first half of 2014.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Exelixis 1st-Quarter Loss Widened as Revenue Slumps Amid Year-Earlier Impacts]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/07/exelixis-1st-quarter-loss-widened-as-revenue-slumps-amid-year-earlier-impacts/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/07/exelixis-1st-quarter-loss-widened-as-revenue-slumps-amid-year-earlier-impacts/</guid>
<pubDate><![CDATA[Tue, 07 May 2013 16:55:21 EDT]]></pubDate>
<description><![CDATA[Exelixis Inc.'s (EXEL) first-quarter loss widened as the biotechnology company's revenue declined mostly owing to $10.7 million in revenue recognized in the year-earlier period related to a licensing agreement.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[MARKET SNAPSHOT: U.S. Stocks Sink; Dow Snaps 4-day Win Streak]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/01/market-snapshot-us-stocks-sink-dow-snaps-4-day-win-streak/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/01/market-snapshot-us-stocks-sink-dow-snaps-4-day-win-streak/</guid>
<pubDate><![CDATA[Wed, 01 May 2013 16:16:57 EDT]]></pubDate>
<description><![CDATA[U.S. stocks declined Wednesday as the Federal Reserve said it would keep buying $85 billion in bonds each month, but may cut or increase the program depending on the economy.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Merck 1st-Quarter Profit Down on Loss of Singulair Exclusivity]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/01/merck-1st-quarter-profit-down-on-loss-singulair-exclusivity/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/01/merck-1st-quarter-profit-down-on-loss-singulair-exclusivity/</guid>
<pubDate><![CDATA[Wed, 01 May 2013 15:58:38 EDT]]></pubDate>
<description><![CDATA[Major drug makers are finding it more difficult than expected to overcome the blow of recent patent expirations, with Merck & Co. (MRK) becoming the second company after Pfizer Inc. (PFE) to report disappointing sales for the first quarter and lower its full-year outlook.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Wall Street Sinks as Oil Sells Off]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2013/05/01/stocks-slide-as-jobs-worries-mount/?]]></link>
<guid>http://www.foxbusiness.com/markets/2013/05/01/stocks-slide-as-jobs-worries-mount/</guid>
<pubDate><![CDATA[Wed, 01 May 2013 15:25:41 EDT]]></pubDate>
<description><![CDATA[Energy and materials stocks were the worst performers on the day as energy futures took a thrashing on the back of a much bigger-than-expected inventory build. ]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Wall Street Thrashed Amid Mounting Economic Worries]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2013/05/01/wall-street-thrashed-amid-mounting-economic-worries/?]]></link>
<guid>http://www.foxbusiness.com/markets/2013/05/01/wall-street-thrashed-amid-mounting-economic-worries/</guid>
<pubDate><![CDATA[Wed, 01 May 2013 15:25:41 EDT]]></pubDate>
<description><![CDATA[Disappointing jobs data and swelling oil inventories ignited worries about the global economy, and sent stocks and energy futures tumbling on Wednesday. ]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/fb2/investing/tiredTrader.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[U.S. Stocks Pare Losses Slightly After Fed Statement]]></title>
<link><![CDATA[http://www.foxbusiness.com/technology/2013/05/01/us-stocks-pare-losses-slightly-after-fed-statement/?]]></link>
<guid>http://www.foxbusiness.com/technology/2013/05/01/us-stocks-pare-losses-slightly-after-fed-statement/</guid>
<pubDate><![CDATA[Wed, 01 May 2013 15:18:45 EDT]]></pubDate>
<description><![CDATA[Stocks held much of their broad losses midday, as investor jitters spread following disappointing economic data and the Federal Reserve's latest statement showed little change in its policy outlook.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[MARKET SNAPSHOT: U.S. Stocks Continue Slide After Fed Decision]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/01/market-snapshot-us-stocks-continue-slide-after-fed-decision/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/01/market-snapshot-us-stocks-continue-slide-after-fed-decision/</guid>
<pubDate><![CDATA[Wed, 01 May 2013 15:01:36 EDT]]></pubDate>
<description><![CDATA[U.S. stocks declined Wednesday as the Federal Reserve said it would keep buying $85 billion in bonds each month, but may cut or increase the program, depending on the economy.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[MARKET SNAPSHOT: U.S. Stocks Curb Slide After Fed Decision]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/01/market-snapshot-us-stocks-curb-slide-after-fed-decision/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/01/market-snapshot-us-stocks-curb-slide-after-fed-decision/</guid>
<pubDate><![CDATA[Wed, 01 May 2013 14:19:23 EDT]]></pubDate>
<description><![CDATA[U.S. stocks came off session lows on Wednesday afternoon after the Federal Reserve said it would maintain its current monetary easing, as expected.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[MARKET SNAPSHOT: U.S. Stocks Sink Before Federal Reserve Decision]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/01/market-snapshot-us-stocks-sink-before-federal-reserve-decision/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/01/market-snapshot-us-stocks-sink-before-federal-reserve-decision/</guid>
<pubDate><![CDATA[Wed, 01 May 2013 13:58:26 EDT]]></pubDate>
<description><![CDATA[U.S. stocks dropped sharply Wednesday, with the S&P 500 index retreating from its all-time high, as corporate revenue fell short of estimates, as did data on private-sector job growth.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[MARKET SNAPSHOT: U.S. Stocks Drop As Companies Miss On Revenue]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/01/market-snapshot-us-stocks-drop-as-companies-miss-on-revenue/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/01/market-snapshot-us-stocks-drop-as-companies-miss-on-revenue/</guid>
<pubDate><![CDATA[Wed, 01 May 2013 13:07:40 EDT]]></pubDate>
<description><![CDATA[U.S. stocks fell Wednesday as companies from MasterCard Inc. to Merck & Co. Inc. reported quarterly results that fell short on revenue and data on private-sector job growth missed the mark.]]></description>
<media:thumbnail/>
</item>
</channel>
</rss>
